LV11894B - Jauni hromāna un tiohromāna atvasinājumi - Google Patents
Jauni hromāna un tiohromāna atvasinājumiInfo
- Publication number
- LV11894B LV11894B LVP-97-111A LV970111A LV11894B LV 11894 B LV11894 B LV 11894B LV 970111 A LV970111 A LV 970111A LV 11894 B LV11894 B LV 11894B
- Authority
- LV
- Latvia
- Prior art keywords
- tiohromána
- jauni
- hromána
- atvasinájumi
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Threshing Machine Elements (AREA)
- Liquid Crystal Substances (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Medicinal Preparation (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Harvester Elements (AREA)
- Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8904361A SE8904361D0 (sv) | 1989-12-22 | 1989-12-22 | New chroman and thiochroman derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV11894A LV11894A (lv) | 1997-12-20 |
| LV11894B true LV11894B (lv) | 1998-05-20 |
Family
ID=20377869
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-819A LV10449B (en) | 1989-12-22 | 1993-06-30 | New chroman and thiochroman derivatives |
| LVP-97-111A LV11894B (lv) | 1989-12-22 | 1997-06-05 | Jauni hromāna un tiohromāna atvasinājumi |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-819A LV10449B (en) | 1989-12-22 | 1993-06-30 | New chroman and thiochroman derivatives |
Country Status (42)
| Country | Link |
|---|---|
| EP (1) | EP0460169B1 (lv) |
| JP (1) | JP2879972B2 (lv) |
| KR (1) | KR0178991B1 (lv) |
| CN (1) | CN1037438C (lv) |
| AT (1) | ATE138918T1 (lv) |
| AU (1) | AU641204B2 (lv) |
| CA (1) | CA2047237C (lv) |
| CY (1) | CY1991A (lv) |
| CZ (1) | CZ283630B6 (lv) |
| DE (1) | DE69027311T2 (lv) |
| DK (1) | DK0460169T3 (lv) |
| DZ (1) | DZ1469A1 (lv) |
| EG (1) | EG19749A (lv) |
| ES (1) | ES2087993T3 (lv) |
| FI (1) | FI102177B1 (lv) |
| GR (1) | GR3020497T3 (lv) |
| HK (1) | HK55897A (lv) |
| HR (1) | HRP920851B1 (lv) |
| HU (1) | HU211860A9 (lv) |
| ID (1) | ID945B (lv) |
| IE (1) | IE80753B1 (lv) |
| IL (1) | IL96712A (lv) |
| IS (1) | IS1665B (lv) |
| LT (1) | LT3967B (lv) |
| LV (2) | LV10449B (lv) |
| MX (1) | MX23889A (lv) |
| NO (1) | NO180336C (lv) |
| NZ (1) | NZ236407A (lv) |
| PH (1) | PH30797A (lv) |
| PL (3) | PL164592B1 (lv) |
| PT (1) | PT96304B (lv) |
| RU (1) | RU2092483C1 (lv) |
| SA (1) | SA90110186B1 (lv) |
| SE (1) | SE8904361D0 (lv) |
| SG (1) | SG48043A1 (lv) |
| SI (1) | SI9012429B (lv) |
| SK (1) | SK280261B6 (lv) |
| TW (1) | TW221056B (lv) |
| UA (1) | UA34416C2 (lv) |
| WO (1) | WO1991009853A1 (lv) |
| YU (2) | YU47936B (lv) |
| ZA (1) | ZA909708B (lv) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5420151A (en) * | 1989-12-22 | 1995-05-30 | Aktiebolaget Astra | Chroman derivatives |
| DE69124868T2 (de) * | 1990-08-15 | 1997-07-10 | Lilly Co Eli | Ring-substituierte 2-Amino-1,2,3,4-tetra-hydronaphthaline, 3-Aminochromane und 3-Aminothiochromane |
| PT712837E (pt) * | 1991-02-08 | 2001-03-30 | Lilly Co Eli | 2-amino-1,2,3,4-tetra-hidronaftalenos de 3-aminocromanos de anel substituido |
| HRP920935A2 (en) * | 1991-10-08 | 1995-08-31 | Astra Ab | New therapeutically active compound |
| SE9103745D0 (sv) * | 1991-12-18 | 1991-12-18 | Wikstroem Haakan | Aryl-triflates and related compounds |
| FR2691149B1 (fr) * | 1992-05-18 | 1994-07-08 | Adir | Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5434174A (en) * | 1992-07-17 | 1995-07-18 | Eli Lilly And Company | Isoxazole derivatives for the treatment of irritable bowel syndrome |
| SE9301732D0 (sv) * | 1993-05-18 | 1993-05-18 | Haakan Wilhelm Wikstroem | New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins |
| SE9703377D0 (sv) | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| SE9703378D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
| US6184226B1 (en) | 1998-08-28 | 2001-02-06 | Scios Inc. | Quinazoline derivatives as inhibitors of P-38 α |
| JP4280068B2 (ja) * | 2001-01-16 | 2009-06-17 | アストラゼネカ・アクチエボラーグ | 治療用クロマン化合物 |
| CN1592745A (zh) | 2001-01-16 | 2005-03-09 | 阿斯特拉曾尼卡有限公司 | 治疗用苯并－γ－吡喃酮化合物 |
| KR100864356B1 (ko) | 2001-01-16 | 2008-10-17 | 아스트라제네카 아베 | 치료용 헤테로시클릭 화합물 |
| US7504395B2 (en) | 2001-07-20 | 2009-03-17 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| US7125904B2 (en) | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
| SE0301796D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use II |
| SE0301795D0 (sv) * | 2003-06-19 | 2003-06-19 | Astrazeneca Ab | New use I |
| US20080221193A1 (en) * | 2006-12-22 | 2008-09-11 | Wyeth | 3-amino chromane derivatives |
| SA08290245B1 (ar) * | 2007-04-23 | 2012-02-12 | استرازينيكا ايه بي | مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم |
| CN101712672B (zh) * | 2008-10-06 | 2013-02-06 | 中国中医科学院中药研究所 | 一种治疗心脑血管系统疾病新化合物及其制备方法、用途 |
| DE102010041948A1 (de) | 2010-10-04 | 2012-04-05 | Mahle International Gmbh | Filtereinrichtung |
| GB201316410D0 (en) | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3679378D1 (de) * | 1985-09-03 | 1991-06-27 | Ciba Geigy Ag | 3-amino-dihydro-(1)-benzopyrane und benzothiopyrane. |
| US4801605A (en) * | 1986-08-29 | 1989-01-31 | Ciba-Geigy Corporation | 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans |
| SE8605504D0 (sv) * | 1986-12-19 | 1986-12-19 | Astra Laekemedel Ab | Novel chroman derivatives |
| US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
-
1989
- 1989-12-22 SE SE8904361A patent/SE8904361D0/xx unknown
-
1990
- 1990-12-03 ZA ZA909708A patent/ZA909708B/xx unknown
- 1990-12-10 NZ NZ236407A patent/NZ236407A/xx unknown
- 1990-12-11 PH PH41705A patent/PH30797A/en unknown
- 1990-12-12 DZ DZ900224A patent/DZ1469A1/fr active
- 1990-12-17 IE IE453590A patent/IE80753B1/en not_active IP Right Cessation
- 1990-12-18 IL IL9671290A patent/IL96712A/en not_active IP Right Cessation
- 1990-12-19 EP EP91901496A patent/EP0460169B1/en not_active Expired - Lifetime
- 1990-12-19 AU AU69770/91A patent/AU641204B2/en not_active Ceased
- 1990-12-19 WO PCT/SE1990/000863 patent/WO1991009853A1/en active IP Right Grant
- 1990-12-19 CA CA002047237A patent/CA2047237C/en not_active Expired - Fee Related
- 1990-12-19 KR KR1019910700957A patent/KR0178991B1/ko not_active IP Right Cessation
- 1990-12-19 DE DE69027311T patent/DE69027311T2/de not_active Expired - Fee Related
- 1990-12-19 ES ES91901496T patent/ES2087993T3/es not_active Expired - Lifetime
- 1990-12-19 JP JP3501912A patent/JP2879972B2/ja not_active Expired - Fee Related
- 1990-12-19 DK DK91901496.9T patent/DK0460169T3/da active
- 1990-12-19 RU SU905001901A patent/RU2092483C1/ru not_active IP Right Cessation
- 1990-12-19 IS IS3662A patent/IS1665B/is unknown
- 1990-12-19 UA UA5001901A patent/UA34416C2/uk unknown
- 1990-12-19 AT AT91901496T patent/ATE138918T1/de not_active IP Right Cessation
- 1990-12-19 SG SG1996006565A patent/SG48043A1/en unknown
- 1990-12-20 EG EG75290A patent/EG19749A/xx active
- 1990-12-20 PT PT96304A patent/PT96304B/pt not_active IP Right Cessation
- 1990-12-21 MX MX2388990A patent/MX23889A/es unknown
- 1990-12-21 CN CN90106068A patent/CN1037438C/zh not_active Expired - Fee Related
- 1990-12-21 PL PL90288405A patent/PL164592B1/pl not_active IP Right Cessation
- 1990-12-21 YU YU242990A patent/YU47936B/sh unknown
- 1990-12-21 CZ CS906578A patent/CZ283630B6/cs not_active IP Right Cessation
- 1990-12-21 SI SI9012429A patent/SI9012429B/sl not_active IP Right Cessation
- 1990-12-21 TW TW079110767A patent/TW221056B/zh active
- 1990-12-21 SK SK6578-90A patent/SK280261B6/sk unknown
- 1990-12-21 PL PL90293065A patent/PL164608B1/pl not_active IP Right Cessation
- 1990-12-21 PL PL90293066A patent/PL164609B1/pl not_active IP Right Cessation
- 1990-12-22 SA SA90110186A patent/SA90110186B1/ar unknown
-
1991
- 1991-04-22 YU YU72191A patent/YU47923B/sh unknown
- 1991-08-21 FI FI913943A patent/FI102177B1/fi not_active IP Right Cessation
- 1991-08-21 NO NO913273A patent/NO180336C/no unknown
-
1992
- 1992-01-30 ID IDP185892A patent/ID945B/id unknown
- 1992-10-02 HR HRP-2429/90A patent/HRP920851B1/xx not_active IP Right Cessation
-
1993
- 1993-06-30 LV LVP-93-819A patent/LV10449B/en unknown
- 1993-12-30 LT LTIP1730A patent/LT3967B/lt not_active IP Right Cessation
-
1995
- 1995-06-30 HU HU95P/P00717P patent/HU211860A9/hu unknown
-
1996
- 1996-07-10 GR GR960401865T patent/GR3020497T3/el unknown
-
1997
- 1997-05-01 HK HK55897A patent/HK55897A/xx not_active IP Right Cessation
- 1997-06-05 LV LVP-97-111A patent/LV11894B/lv unknown
- 1997-09-05 CY CY199197A patent/CY1991A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW221056B (lv) | ||
| AU1808488A (en) | Compounds for the treatment of alzheimer's disease | |
| HU903961D0 (en) | Process for producing 11-beta-aryl-4-oestrenes and pharmaceutical preparatives containing these compounds | |
| AR243180A1 (es) | Procedimiento para la obtencion de 3,4-dihidro-2h-benzopiranos sustituidos. | |
| IL88971A (en) | Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them | |
| HUT47430A (en) | Process for producing pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for treating alcoholizmus | |
| IL88726A0 (en) | Dihydrothienobenzodiazepinone derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof | |
| YU45183B (en) | 4-oxothiazolidin-2-iliden-acetamidni derivat formule (i) | |
| HU9200400D0 (en) | Cinurenic acid derivatives, process for producing them and pharmaceutical compositions containing them | |
| HU9201306D0 (en) | Process for the production of medical preparations for treating anxiety, containing r/+/-3-amino-1-hydroxy-pyrolydin-2-on | |
| GR3001809T3 (en) | Benzylaminoaryldihydropyridine lactones, process for their preparation and their use in medicaments | |
| CS105489A2 (en) | Method of veterinary preparations production suitable especially for mastitis treatment | |
| IT1243947B (it) | 2-azido-ornitina, sua preparazione e suo impiego in terapia |